Champions Oncology, Inc. (FRA:2I3)
Germany flag Germany · Delayed Price · Currency is EUR
5.40
-0.10 (-1.82%)
Last updated: Dec 1, 2025, 3:29 PM CET

Champions Oncology Ratios and Metrics

Millions EUR. Fiscal year is May - Apr.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Apr '25 Apr '24 Apr '23 Apr '22 Apr '21 2016 - 2020
7186626099119
Upgrade
Market Cap Growth
20.35%40.09%2.01%-38.66%-17.49%42.38%
Upgrade
Enterprise Value
6789655899119
Upgrade
Last Close Price
5.406.404.504.427.409.15
Upgrade
PE Ratio
27.5820.85--189.51396.90
Upgrade
PS Ratio
1.431.721.321.242.123.50
Upgrade
PB Ratio
23.0125.98-34.6514.3911.4219.34
Upgrade
P/TBV Ratio
25.6628.51-15.5111.8520.26
Upgrade
P/FCF Ratio
11.2414.01-60.6425.25-
Upgrade
P/OCF Ratio
10.6113.27-16.8015.99-
Upgrade
EV/Sales Ratio
1.381.781.381.192.133.48
Upgrade
EV/EBITDA Ratio
12.3215.65--46.9092.05
Upgrade
EV/EBIT Ratio
26.0420.94--172.63389.82
Upgrade
EV/FCF Ratio
10.6514.51-58.1225.48-
Upgrade
Debt / Equity Ratio
1.681.68-3.901.861.041.29
Upgrade
Debt / EBITDA Ratio
0.930.76--2.293.37
Upgrade
Debt / FCF Ratio
0.820.90-7.822.30-
Upgrade
Asset Turnover
2.051.951.661.551.561.70
Upgrade
Quick Ratio
0.870.880.560.831.061.04
Upgrade
Current Ratio
0.930.940.630.901.131.13
Upgrade
Return on Equity (ROE)
182.28%503.05%-532.46%-77.70%6.63%5.78%
Upgrade
Return on Assets (ROA)
6.78%10.36%-14.31%-7.98%1.21%0.95%
Upgrade
Return on Capital (ROIC)
23.16%38.77%-46.11%-17.49%2.13%1.76%
Upgrade
Return on Capital Employed (ROCE)
38.40%57.10%-150.80%-35.40%3.40%2.20%
Upgrade
Earnings Yield
3.63%4.80%-11.04%-8.00%0.53%0.25%
Upgrade
FCF Yield
8.89%7.14%-10.58%1.65%3.96%-3.45%
Upgrade
Buyback Yield / Dilution
-4.67%-5.31%-0.04%4.37%2.84%-23.05%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.